A blog about our discoveries and community

Startup life

Midsummer updates

Perlara midsummer 2017 updates—We took a temporary hiatus from blogging starting in March right after my Rare Disease Day post. The reason: fundraising. Raising money is personally all-consuming for the CEO, as I'll attest in an upcoming post. It's also a...

Perlara science

World Rare Disease Day 2017

This post is dedicated to World Rare Disease Day (WRDD) 2017. It was at the WRRD four years earlier when the value proposition for Perlara crystalized in my mind. I went to NIH that frosty last day of February in order to meet with patient advocates and ask them...

Perlara science

Optimizing my first High Throughput Screen

I, along with Nina, performed our first high-throughput screen – well really medium-throughput but high-throughput for us – on Niemann-Pick Type C (NPC) patient-derived fibroblasts a couple of months back. We wanted to do a pilot screen with the Microsource...

Perlara science

NPC1 KO mouse brain study

Well it has been a little while since I wrote a post, and a lot has happened since then, which I am sure you read about in our blogs and tweets. We changed our company name, partnered with Novartis and started partnering with patient groups to engineer our...

Last Month in Tweets

2016 in review

"Last Month in Tweets" was on again, off again in 2016. Apologies, we'll be more consistent with monthly updates across the board in 2017. For now, let's relive the best moments of 2016 at Perlara! Although I wasn't able to announce it publicly for several months,...

Perlara science

Perlara’s first preprint

Two weeks ago we posted Perlara's first preprint to bioRxiv, along with all the raw data on GitHub: https://twitter.com/biorxivpreprint/status/796019478999998465 This effort was led entirely by a very talented undergrad named Maria Teresa Chavez, who reached out to...

Perlara science

Echo 550 acoustic liquid handling technology

High throughput screening (HTS) is essential in the process of finding a potential drug candidate, and automation is key for a good screen both in terms of robustness and efficiency. I kept hearing about the Echo since the day I joined Perlara, but it was only...

NGLY1

Our talk for the 2016 Grace Science Foundation Meeting

This past weekend was the 2016 Grace Science Foundation Meeting in Palo Alto.  It was a great success!  Here are the slides from my talk, with a few blurbs about them and what's to come. Curious about this?  Check out my first blog on making NGLY1 flies.  Prior to...

Startup life

Introducing Perlara

Last month at the 5th annual Global Genes Patient Summit, we announced our rebrand from Perlstein Lab PBC to Perlara PBC. Together with our partners at Valley Design Group, we created a new logo/mark that embodies the excitement and hope of scientific discovery. To...

Perlara logo 300x108px

Join our mailing list

Translate »